Viewing StudyNCT00412646



Ignite Creation Date: 2024-05-05 @ 5:15 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00412646
Status: COMPLETED
Last Update Posted: 2010-04-28
First Post: 2006-12-15

Brief Title: TMC125-C203 Phase II Randomized Patients Are Assigned Different Treatments Based on Chance Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients
Sponsor: Tibotec Pharmaceuticals Ireland
Organization: Tibotec Pharmaceuticals Ireland

Organization Data

Organization: Tibotec Pharmaceuticals Ireland
Class: INDUSTRY
Study ID: CR006754
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Tibotec Pharmaceuticals Ireland
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: None
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators